Connection
Tatiana Kutateladze to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Tatiana Kutateladze has written about TOR Serine-Threonine Kinases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.039 |
|
|
|
-
Acharya A, Pathania AS, Pandey K, Thurman M, Vann KR, Kutateladze TG, Challagundala KB, Durden DL, Byrareddy SN. PI3K-a/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron. Clin Transl Med. 2022 04; 12(4):e806.
Score: 0.039